XI
Xintela AB (publ)
XINT.ST · STO
0.16 kr -3.03% (-0.01 kr)
1M -16.67%
Market Cap 137.8M kr
P/E Ratio -
Div. Yield -
ROE -
Bulios Fair Price
0.23 kr
43.8% upside
Trenutna cena
0.16 kr
Podcenjeno Poštena vrednost Precenjeno
Po podatkih Bulios Fair Price je delnica XINT.ST trenutno podcenjena glede na svojo tržno ceno. Kako deluje?
Bulios Fair Price je ocena poštene vrednosti delnice iz Buliosovega modela vrednotenja. Je vhod za vašo lastno analizo, ne naložbeno priporočilo. Kako deluje?
Piotroski F-Score Weak
2/9Valuation
0 /100
Expensive P/S 60.39x
P/E N/A
EV/EBITDA N/A
Growth
-
N/A EPS growth N/A
Rev. growth N/A
Book val. growth N/A
Profitability
22 /100
Weak Gross margin 73.44%
Net margin 2,128.13%
FCF margin 0.00%
Quality
59 /100
Average ROIC 857.21%
ROA 167.32%
Asset turnover 0.08x
Debt
12 /100
High Current ratio 0.84x
Int. coverage -13.39x
Debt/Equity N/A
Stability
26 /100
Unstable Beta 1.97x
EPS volatility 35.19%
Profitable years 0
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
Vprašajte StockBota o XINT.ST
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Evy Lundgren-Åkerlund Assoc.Prof
Employees
11
Headquarters
Lund
Prihajajoči dogodki
27 NOV.
Earnings
Upcoming earnings report